All posts by: Michael Zand

WideCells signs deal to roll out CellPlan stem cell services to Hemocord Medica Ltd – Proactive Investors UK

Proactive Investors UKWideCells signs deal to roll out CellPlan stem cell services to Hemocord Medica LtdProactive Investors UKWideCells Group plc (LON:WDC) has signed a definitive agreement with Brazilian cord blood storage facility, Hemocord Clinica … Continue reading

Stem cell-based therapies to treat spinal cord injury: a review – Dove Medical Press

Stem cell-based therapies to treat spinal cord injury: a reviewDove Medical PressAbstract: Spinal cord injury (SCI) is a devastating condition and major burden on society and individuals. Currently, neurorestorative strategies, including stem cell ther… Continue reading

Tests show no signs of cancer for Danville 2-year-old – GoDanRiver.com

GoDanRiver.comTests show no signs of cancer for Danville 2-year-oldGoDanRiver.comDr. William Clark with the Massey Cancer Center at Virginia Commonwealth University will speak about bone marrow and stem cell transplants from 11:30 a.m. to 1 p.m. July … Continue reading

Canadian clinics begin offering stem-cell treatments experts call unproven, possibly unsafe – National Post

Genemods June newsreel and new podcast – PLoS Blogs (blog)

Genemods June newsreel and new podcastPLoS Blogs (blog)The Synbio Newsreel is guest contributed by Isaac Larkin from the Northwestern University synthetic biology club called GeneMods. This post can be originally found as part of their monthly SynBio … Continue reading

Greater understanding of plant hormone results in stem cells that grow shoots – Phys.Org

Phys.OrgGreater understanding of plant hormone results in stem cells that grow shootsPhys.OrgResearchers at Dartmouth College have identified how a well-known plant hormone targets genes to regulate plant growth and development. The finding could allow… Continue reading

China sides with Berkeley on CRISPR patent – BioNews

China sides with Berkeley on CRISPR patentBioNewsCRISPR intellectual property rights are the subject of an ongoing dispute in the USA between the University of California who were first to file and hold a general patent, and the Broad Institute, whose … Continue reading